Greenfield Seitz Capital Management’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.63M Buy
14,151
+307
+2% +$134K 1.68% 21
2026
Q1
$6.38M Buy
13,844
+20
+0.1% +$10.1K 1.92% 14
2025
Q4
$7.83M Sell
13,824
-66
-0.5% -$35.1K 2.57% 9
2025
Q3
$6.21M Buy
13,890
+297
+2% +$143K 2% 13
2025
Q2
$7.39M Buy
13,593
+295
+2% +$154K 2.61% 8
2025
Q1
$6.59M Sell
13,298
-147
-1% -$81.3K 2.51% 11
2024
Q4
$7.02M Sell
13,445
-28
-0.2% -$14.6K 2.67% 8
2024
Q3
$6.62M Sell
13,473
-452
-3% -$210K 2.42% 12
2024
Q2
$6.19M Sell
13,925
-37
-0.3% -$14.7K 2.29% 12
2024
Q1
$5.57M Sell
13,962
-470
-3% -$178K 2.08% 16
2023
Q4
$4.87M Buy
+14,432
New +$4.3M 1.94% 15

Other funds holding ISRG

Greenfield Seitz Capital Management's ISRG Position: Q2 2026 in Review

Greenfield Seitz Capital Management increased its Intuitive Surgical (ISRG) stake by 2.2% in Q2 2026, buying an estimated $134K and bringing the position to 14,151 shares worth $5.63M. The position accounts for 1.68% of the portfolio, ranked #21.

Greenfield Seitz Capital Management first reported a position in ISRG in Q4 2023 and has held it in 11 quarters since. The position peaked at $7.83M in Q4 2025. 2,240 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.

  • Greenfield Seitz Capital Management held 14,151 shares of Intuitive Surgical worth $5.63M as of Q2 2026.
  • Greenfield Seitz Capital Management bought 307 Intuitive Surgical shares in Q2 2026, an estimated $134K.
  • Intuitive Surgical made up 1.68% of Greenfield Seitz Capital Management's portfolio in Q2 2026, its #21 holding.
  • Greenfield Seitz Capital Management first reported a position in Intuitive Surgical in Q4 2023 and has held it in 11 quarters since.
  • Greenfield Seitz Capital Management's Intuitive Surgical position peaked at $7.83M in Q4 2025.
  • 2,240 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.

Based on Greenfield Seitz Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.